CSBTF (Kuros Biosciences) Interest Expense: $-0.3 Mil (TTM As of Dec. 2025)

What is Kuros Biosciences Interest Expense?

Kuros Biosciences CSBTF 71 Interest Expense is $-0.3 Mil as of Dec. 2025. GuruFocus rates CSBTF with a GF Score™ of 71/100 and a GF Value™ of $54.72 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Kuros Biosciences's interest expense for the six months ended in Dec. 2025 was $ 5.1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Kuros Biosciences's Operating Income for the six months ended in Dec. 2025 was $ 7.7 Mil. Kuros Biosciences's Interest Expense for the six months ended in Dec. 2025 was $ 5.1 Mil. Kuros Biosciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kuros Biosciences (OTCPK:CSBTF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kuros Biosciences's Interest Expense for the six months ended in Dec. 2025 was $5.1 Mil. Its Operating Income for the six months ended in Dec. 2025 was $7.7 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was $0.9 Mil.

Kuros Biosciences's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Kuros Biosciences Interest Expense Historical Data

* Premium members only.

The historical data trend for Kuros Biosciences's Interest Expense can be seen below:

Kuros Biosciences Interest Expense Chart

Kuros Biosciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-1.50

-0.16

-0.22

-0.19

-0.46

Kuros Biosciences Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Interest Expense	Get a 7-Day Free Trial															0.99	-0.49	0.30	-5.46	5.11

71GF Score

Kuros Biosciences Ltd CSBTF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Kuros Biosciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.3 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.3 Mil mean?

Kuros Biosciences (CSBTF) has a Interest Expense of $-0.3 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Kuros Biosciences and its competitors.

Is Kuros Biosciences' Interest Expense too high?

Kuros Biosciences' current Interest Expense is $-0.3 Mil. Overall, Kuros Biosciences has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Kuros Biosciences' Interest Expense compare to ABT and SYK?

Kuros Biosciences' Interest Expense of $-0.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Kuros Biosciences and its competitors. Kuros Biosciences's current Interest Expense is $-0.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Kuros Biosciences stock overvalued right now?

Based on GuruFocus' analysis, Kuros Biosciences (CSBTF) is currently considered Significantly Undervalued. The stock's GF Value™ is $54.72, compared to a current price of $22.72 — trading 58.5% below its estimated fair value. The current Interest Expense is $-0.3 Mil. Kuros Biosciences' overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Kuros Biosciences (CSBTF), the current Interest Expense is $-0.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kuros Biosciences (CSBTF) Overvalued in 2026?

Based on GuruFocus' analysis, Kuros Biosciences stock appears to be undervalued. The current stock price of $22.72 is trading 58.5% below its estimated GF Value™ of $54.72. GuruFocus considers Kuros Biosciences to be Significantly Undervalued.

Key valuation signals for CSBTF:

Interest Expense: $-0.3 Mil
GF Value™: $54.72 vs. price of $22.72 (58.5% below fair value)
GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the CSBTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kuros Biosciences Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies XSWX:MED XSWX:METN XSWX:MOVE ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA STE ZBH XSWX:SOON SHSE:688271 LSE:SN.PEN TSE:7733

Other Exchanges KURNz:UK 0RHR:UK YTSN:Germany KURN:Switzerland

Address Wagistrasse 25, Schlieren, Zurich, CHE, 8952

Website https://www.kurosbio.com

Kuros Biosciences Ltd is a Swiss-based biotech company, focused on developing and commercializing biologic bone graft technologies for musculoskeletal applications, particularly in spine, trauma, extremities, and oncology. It has two reportable segments: i) Medical Devices: This segment includes products such as MagnetOs and Attrax, which are biphasic calcium phosphate (BCP) bone grafts that mimic the porous, trabecular structure of cancellous bone. ii) Legacy Portfolio: This segment includes all non-core products (including Checkmate licensing) that are outside the Group's primary therapeutic focus. The majority of the company's revenue is derived from the Medical Devices segment. Geographically, it generates the maximum revenue from the United States of America.

71GF Score

Get the complete analysis for CSBTF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.72

Price

$54.72

GF Value

View CSBTF Analysis

See Interest Expense data for all stocks →